IRLAB Therapeutics AB (publ) (STO:IRLAB.A)
1.862
+0.024 (1.31%)
Oct 13, 2026, 12:39 PM CET
IRLAB Therapeutics AB Employees
IRLAB Therapeutics AB had 31 employees as of June 30, 2026. The number of employees increased by 1 or 3.33% compared to the same quarter last year. That makes IRLAB Therapeutics AB the 36,942nd largest employer in the world and 507th in Sweden.
Employees
31
Change
1
Growth
3.33%
Revenue / Employee
2.56M SEK
Profits / Employee
-1.74M SEK
Market Cap
276.90M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 31 | 1 | 3.33% |
| Mar 31, 2026 | 31 | 1 | 3.33% |
| Dec 31, 2025 | 31 | 0 | - |
| Sep 30, 2025 | 31 | -1 | -3.13% |
| Jun 30, 2025 | 30 | -2 | -6.25% |
| Mar 31, 2025 | 30 | -2 | -6.25% |
| Dec 31, 2024 | 31 | -3 | -8.82% |
| Sep 30, 2024 | 32 | 1 | 3.23% |
| Jun 30, 2024 | 32 | 1 | 3.23% |
| Mar 31, 2024 | 32 | 1 | 3.23% |
| Dec 31, 2023 | 34 | 3 | 9.68% |
| Sep 30, 2023 | 31 | 0 | - |
| Jun 30, 2023 | 31 | 3 | 10.71% |
| Mar 31, 2023 | 31 | 7 | 29.17% |
| Sep 30, 2022 | 31 | 3 | 10.71% |
| Jun 30, 2022 | 28 | 1 | 3.70% |
| Mar 31, 2022 | 24 | -1 | -4.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Diamyd Medical AB | 42 |
| Sprint Bioscience AB | 32 |
| Xbrane Biopharma AB | 29 |
| Cantargia AB | 22 |
| Mendus AB | 19 |
| Intervacc AB | 16 |
| Corline Biomedical AB | 14 |
| Xintela AB | 11 |
IRLAB Therapeutics AB News
- 6 weeks ago - IRLAB Therapeutics AB Quarterly report: Q2 2026 - Filings
- 6 weeks ago - IRLAB Therapeutics AB Slides: Q2 2026 - Filings
- 5 months ago - IRLAB Therapeutics AB Quarterly report: Q1 2026 - Filings
- 5 months ago - IRLAB Therapeutics AB Slides: Q1 2026 - Filings
- 7 months ago - IRLAB Therapeutics AB Quarterly report: Q4 2025 - Filings
- 7 months ago - IRLAB Therapeutics AB Slides: Q4 2025 - Filings
- 7 months ago - IRLAB Therapeutics AB Annual report: Q4 2025 - Filings
- 11 months ago - IRLAB Therapeutics AB Quarterly report: Q3 2025 - Filings